Be-Sheng Kuo
Corporate Officer/Principal at AbGenomics International, Inc.
Be-Sheng Kuo active positions
| Companies | Position | Start | End |
|---|---|---|---|
AbGenomics International, Inc.
 AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | Corporate Officer/Principal | - | - |
Career history of Be-Sheng Kuo
Former positions of Be-Sheng Kuo
| Companies | Position | Start | End |
|---|---|---|---|
IDEC Pharmaceuticals Corp.
 IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01/01/1999 | 01/01/2003 |
| Parke-Davis Pharmaceutical Research, Inc. | Chief Tech/Sci/R&D Officer | 01/01/1993 | 01/01/1999 |
| Marion Merrell Dow, Inc. | Chief Tech/Sci/R&D Officer | 01/01/1988 | 01/01/1993 |
Training of Be-Sheng Kuo
| University of Cincinnati (Ohio) | Doctorate Degree |
Statistics
International
| United States | 6 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
AbGenomics International, Inc.
AbGenomics International, Inc. Pharmaceuticals: MajorHealth Technology AbGenomics International, Inc. manufactures biopharmaceutical therapeutics. The firm produces therapeutics for the treatment of cancer and immune related inflammatory diseases. It also performs research discovery, preclinical and clinical development, as well as strategic planning for commercialization of its therapeutics. The company was founded by Rong-Hwa Lin in 2000 and is headquartered in Los Altos, CA. | Health Technology |
IDEC Pharmaceuticals Corp.
IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
| Parke-Davis Pharmaceutical Research, Inc. | |
| Marion Merrell Dow, Inc. | Health Technology |
- Stock Market
- Insiders
- Be-Sheng Kuo
- Experience
